Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment…
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that Gaurav…
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative…
− Ongoing Phase 1/2a Study of CD19 CAR-NK with Pivotal Study Expected to Enroll Patients in 2021 − Potential to…
NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the expiration date of the offers to…
DUBLIN–(BUSINESS WIRE)–The “Red Biotechnology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027” report has been added…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#oncology—Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced the appointment…
Plenity-treated adults achieving a BMI of <27 lost an average of 13.5% of their weight with the rate of weight…
DUBLIN–(BUSINESS WIRE)–The “Ovarian Cancer: Opportunity Analysis and Forecasts to 2028” report has been added to ResearchAndMarkets.com’s offering. Ovarian Cancer: Opportunity…